1,10-Phenanthroline Inhibits the Metallopeptidase Secreted by Phialophora verrucosa and Modulates its Growth, Morphology and Differentiation
- 182 Downloads
Phialophora verrucosa is one of the etiologic agents of chromoblastomycosis, a fungal infection that affects cutaneous and subcutaneous tissues. This disease is chronic, recurrent and difficult to treat. Several studies have shown that secreted peptidases by fungi are associated with important pathophysiological processes. Herein, we have identified and partially characterized the peptidase activity secreted by P. verrucosa conidial cells. Using human serum albumin as substrate, the best hydrolysis profile was detected at extreme acidic pH (3.0) and at 37 °C. The enzymatic activity was completely blocked by classical metallopeptidase inhibitors/chelating agents as 1,10-phenanthroline and EGTA. Zinc ions stimulated the metallo-type peptidase activity in a dose-dependent manner. Several proteinaceous substrates were cleaved, in different extension, by the P. verrucosa metallopeptidase activity, including immunoglobulin G, fibrinogen, collagen types I and IV, fibronectin, laminin and keratin; however, mucin and hemoglobin were not susceptible to proteolysis. As metallopeptidases participate in different cellular metabolic pathways in fungal cells, we also tested the influence of 1,10-phenanthroline and EGTA on P. verrucosa development. Contrarily to EGTA, 1,10-phenanthroline inhibited the fungal viability (MIC 0.8 µg/ml), showing fungistatic effect, and induced profound morphological alterations as visualized by transmission electron microscopy. In addition, 1,10-phenanthroline arrested the filamentation process in P. verrucosa. Our results corroborate the supposition that metallopeptidase inhibitors/chelating agents have potential to control crucial biological events in fungal agents of chromoblastomycosis.
KeywordsPhialophora verrucosa Chromoblastomycosis Metallopeptidase 1,10-Phenanthroline Growth Differentiation
This work was supported mainly by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). This study was also financed by Grants from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundação Oswaldo Cruz (FIOCRUZ).
Conflict of interest
- 1.Rippon JW. Chromoblastomycosis. In: Medical mycology: the pathogenic fungi and the pathogenic actinomycetes. WB Saunders: Philadelphia; 1988. p. 276–96.Google Scholar
- 14.Palmeira VF, Kneipp LF, Alviano CS, Santos ALS. The major chromoblastomycosis fungal pathogen, Fonsecaea pedrosoi, extracellularly releases proteolytic enzymes whose expression is modulated by culture medium composition: implications on the fungal development and cleavage of key’s host structures. FEMS Immunol Med Microbiol. 2006;46:21–9.CrossRefPubMedGoogle Scholar
- 20.CLSI. Clinical Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: second edition (M38-A2). Wayne: CLSI; 2008.Google Scholar
- 26.Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010;23:884–928. Erratum in: Clin Microbiol Rev. 2012;25:720.Google Scholar
- 34.Gravi ET, Paschoalin T, Dias BR, Moreira DF, Belizario JE, Oliveira V, Carmona AK, Juliano MA, Travassos LR, Rodrigues EG. Identification of a metallopeptidase with TOP-like activity in Paracoccidioides brasiliensis, with increased expression in a virulent strain. Med Mycol. 2012;50:81–90.CrossRefPubMedGoogle Scholar
- 39.Brul S, Stratford M, Van der Vaart JM, Dielbandhoesing SK, Steels H, Klis FM, Verrips CT. The antifungal action of 1,10-phenanthroline and EDTA is mediated through zinc chelation and involves cell wall construction. Food Technol Biotech. 1997;35:267–74.Google Scholar
- 42.Santos ALS, Sodré CL, Valle RS, Silva BA, Abi-Chacra EA, Silva LV, Souza-Goncalves AL, Sangenito LS, Goncalves DS, Souza LO, Palmeira VF, d’Avila-Levy CM, Kneipp LF, Kellett A, McCann M, Branquinha MH. Antimicrobial action of chelating agents: repercussions on the microorganism development, virulence and pathogenesis. Curr Med Chem. 2012;19:2715–37.CrossRefPubMedGoogle Scholar